¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"egg concentration technique"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
lethal concentration
Ä¡»ç³óµµ(öÈÞÝÒØÓø)
maximum permissible concentration
ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØÓø)
normalized substrate concentration
³ë¸£¸» ±âÁú³óµµ(ѨòõÒØÓø)
osmotic concentration
»ïÅõ³óµµ(ß¶÷âÒØÓø)
reduced substrate concentration
ȯ»ê ±âÁú ³óµµ(üµß©Ñ¨òõÒØÓø)
relative substrate concentration
»ó´ë ±âÁú³óµµ(ßÓÓßÐñòõÒØÓø)
saturating substrate concentration
Æ÷È ±âÁú³óµµ(øéûùÐñòõÒØÓø)
second critical concentration
Á¦(ð¯) 2 ÇѰè³óµµ(ùÚÍ£ÒØÓø)
specific substrate concentration
ƯÀÌ ±âÁú³óµµ(÷åì¶ÐñòõÒØÓø)
anticomplement fluorescent antibody technique
Ç׺¸Ã¼ Çü±¤Ç×ü¼ú(ù÷ÜÍô÷û«ÎÃù÷ô÷âú)
competitive protein-binding technique
°æÇÕÀû ´Ü¹éÁú °áÇÕ¼ú(ÌæùêîÜÓ±ÛÜòõÌ¿ùêâú)
continuous flow technique
"¿¬¼Ó(ææáÙ)È帧¼ú(âú), (ÔÒ) rapid flow technique"
direct fluorescent antibody technique
Á÷Á¢ Çü±¤ Ç×ü¼ú(òÁïÈû«ÎÃù÷ô÷âú)
DNA-agar technique
DNAÇÑõ(ùÎô¸) ¼ú(âú)
double-blind technique
ÀÌÁ߸Ͱ˼ú(ì£ñìØîËþâú)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½